Deutsche Bank AG purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 1,005,780 shares of the company's stock, valued at approximately $238,933,000. Deutsche Bank AG owned 0.43% of Cardinal Health at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also made changes to their positions in the stock. University of Texas Texas AM Investment Management Co. acquired a new stake in Cardinal Health in the fourth quarter valued at approximately $26,000. Bank of Jackson Hole Trust purchased a new stake in shares of Cardinal Health in the 4th quarter valued at approximately $27,000. Jones Financial Companies Lllp raised its holdings in shares of Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock valued at $27,000 after purchasing an additional 14,034 shares in the last quarter. Palladiem LLC acquired a new stake in shares of Cardinal Health in the 4th quarter valued at $28,000. Finally, Indiana Trust & Investment Management Co purchased a new stake in shares of Cardinal Health during the 1st quarter worth $29,000. Hedge funds and other institutional investors own 87.17% of the company's stock.
Cardinal Health Price Performance
CAH stock opened at $234.85 on Wednesday. The company has a market cap of $54.62 billion, a price-to-earnings ratio of 32.48, a price-to-earnings-growth ratio of 1.26 and a beta of 0.49. The company has a fifty day moving average price of $231.38 and a 200 day moving average price of $217.51. Cardinal Health, Inc. has a 12 month low of $145.87 and a 12 month high of $258.30.
Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.42 by $0.49. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The company had revenue of $63.67 billion for the quarter, compared to the consensus estimate of $65.15 billion. During the same period last year, the firm posted $2.08 EPS. Cardinal Health's revenue for the quarter was up 5.8% on a year-over-year basis. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, analysts anticipate that Cardinal Health, Inc. will post 12.54 earnings per share for the current year.
Cardinal Health Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be given a $0.5158 dividend. This represents a $2.06 annualized dividend and a yield of 0.9%. The ex-dividend date is Thursday, October 1st. Cardinal Health's payout ratio is 28.49%.
Analyst Ratings Changes
A number of equities analysts recently commented on the stock. William Blair began coverage on shares of Cardinal Health in a research note on Tuesday, April 28th. They set an "outperform" rating for the company. UBS Group lifted their price target on Cardinal Health from $274.00 to $280.00 and gave the stock a "buy" rating in a report on Wednesday, August 12th. Zacks Research cut Cardinal Health from a "strong-buy" rating to a "hold" rating in a research report on Friday, June 12th. Mizuho increased their price objective on Cardinal Health from $240.00 to $250.00 and gave the company an "outperform" rating in a report on Wednesday, August 12th. Finally, Weiss Ratings raised Cardinal Health from a "buy (b)" rating to a "buy (b+)" rating in a research report on Wednesday, August 5th. Fifteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Cardinal Health presently has an average rating of "Moderate Buy" and an average target price of $265.93.
Read Our Latest Report on Cardinal Health
About Cardinal Health
(
Free Report)
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
